tradingkey.logo

CeriBell Inc

CBLL
查看詳細走勢圖
20.150USD
+0.810+4.19%
收盤 02/06, 16:00美東報價延遲15分鐘
746.53M總市值
虧損本益比TTM

CeriBell Inc

20.150
+0.810+4.19%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+4.19%

5天

-2.23%

1月

-11.74%

6月

+60.17%

今年開始到現在

-8.12%

1年

-5.27%

查看詳細走勢圖

TradingKey CeriBell Inc股票評分

單位: USD 更新時間: 2026-02-06

操作建議

CeriBell Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業領先水平。增長潛力很大。當前估值合理,在醫療設備與耗材行業排名57/205位。機構持股佔比非常高,近一月多位分析師給出公司評級為強力買入。最高目標價為28.14。中期看,股價處於上升通道。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

CeriBell Inc評分

相關信息

行業排名
57 / 205
全市場排名
161 / 4521
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
看空

CeriBell Inc亮點

亮點風險
CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
業績高增長
公司營業收入穩步增長,連續3年增長152.47%
業績增長期
公司處於發展階段,最新年度總收入65.44M美元
估值合理
公司最新PE估值-14.32,處於3年歷史合理位
機構減倉
最新機構持股30.92M股,環比減少0.09%
PRFDX持倉
明星投資者PRFDX持倉,最新持倉2.34K股

分析師目標

基於 8 分析師
強力買入
評級
28.143
目標均價
+39.67%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

CeriBell Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

CeriBell Inc簡介

CeriBell, Inc. is a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
公司代碼CBLL
公司CeriBell Inc
CEOChao (Xingjuan)
網址https://ceribell.com/
KeyAI